| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.14B | 137.61B | 122.45B | 121.34B | 91.11B | 85.22B |
| Gross Profit | 23.96B | 24.12B | 18.84B | 16.16B | 7.49B | 11.12B |
| EBITDA | 9.96B | 9.99B | 7.61B | 6.01B | -4.55B | 3.15B |
| Net Income | 4.01B | 3.90B | 2.31B | 849.00M | -7.02B | -3.36B |
Balance Sheet | ||||||
| Total Assets | 109.90B | 106.83B | 102.75B | 92.87B | 86.15B | 77.23B |
| Cash, Cash Equivalents and Short-Term Investments | 19.52B | 21.50B | 20.86B | 13.65B | 13.19B | 21.09B |
| Total Debt | 9.29B | 8.57B | 16.94B | 17.46B | 13.37B | 5.20B |
| Total Liabilities | 37.00B | 38.09B | 38.42B | 36.35B | 34.51B | 21.23B |
| Stockholders Equity | 64.49B | 60.87B | 58.01B | 51.10B | 47.16B | 50.64B |
Cash Flow | ||||||
| Free Cash Flow | 4.69B | 11.21B | 10.67B | -2.18B | -15.43B | -1.36B |
| Operating Cash Flow | 10.43B | 14.83B | 15.43B | 354.00M | -12.77B | 739.00M |
| Investing Cash Flow | -1.86B | -844.00M | -8.54B | -1.32B | -3.07B | -1.96B |
| Financing Cash Flow | -9.46B | -9.88B | -4.44B | 1.78B | 6.77B | -2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥69.76B | 23.18 | ― | 2.73% | -0.70% | 33.64% | |
69 Neutral | ¥173.91B | 9.04 | 13.53% | 1.34% | -3.63% | -14.77% | |
62 Neutral | ¥86.02B | 9.53 | ― | 1.99% | -0.29% | 119.59% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥7.76T | -69.04 | 4.25% | 1.99% | -7.70% | -39.06% | |
56 Neutral | ¥19.11T | -5.95 | 14.45% | 0.55% | -12.56% | -119.49% | |
54 Neutral | ¥2.71B | -0.65 | ― | 4.68% | -3.51% | -4384.38% |